RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Vident Advisory, LLC's Holding History (CIK: 0001744347)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025

Shares 10,125 Value ($000) $54 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 11,772 Value ($000) $80 Avg Close $6.72 Range $5.60 - $9.55

Q2 2024

Shares 18,363 Value ($000) $138 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 18,761 Value ($000) $187 Avg Close $11.14 Range $8.68 - $15.74

Q4 2023

Shares 19,768 Value ($000) $195 Avg Close $7.13 Range $4.97 - $11.17

Q3 2023

Shares 27,149 Value ($000) $208 Avg Close $9.98 Range $6.44 - $16.75

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2025	10,125	$54	$7.29	$5.19 - $12.36
Q4 2024	11,772	$80	$6.72	$5.60 - $9.55
Q2 2024	18,363	$138	$8.72	$6.75 - $10.66
Q1 2024	18,761	$187	$11.14	$8.68 - $15.74
Q4 2023	19,768	$195	$7.13	$4.97 - $11.17
Q3 2023	27,149	$208	$9.98	$6.44 - $16.75